← Eichor
Study identifier: NCT02883647 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

Condition: Chronic Hepatitis b  ·  Sponsor: Third Affiliated Hospital, Sun Yat-Sen University

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The study is to observe the therapeutic effects and long-term follow-up after ending anti-HBV therapy with nucleos(t)ide analogs in patients with chronic hepatitis b.

This description comes directly from the study's public registry record.

Talk to the study team

Wenxiong Xu, Master  ·  +8613760783281  ·  xwx1983@163.com

Liang Peng, Doctor  ·  +8613533978874  ·  pzp33@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02883647